Michal Kaza
Michal Kaza
Lukasiewicz Research Network - Pharmaceutical Research Institute
Zweryfikowany adres z ifarm.eu - Strona główna
Tytuł
Cytowane przez
Cytowane przez
Rok
Application of a microbiotests battery for complete toxicity assessment of rivers
J Mankiewicz-Boczek, G Nałęcz-Jawecki, A Drobniewska, M Kaza, ...
Ecotoxicology and Environmental Safety 71 (3), 830-836, 2008
952008
Toxicity Assessment of Water Samples from Rivers in Central Poland Using a Battery of Microbiotests--a Pilot Study.
M Kaza, J Mankiewicz-Boczek, K Izydorczyk, J Sawicki
Polish Journal of Environmental Studies 16 (1), 2007
412007
Validated HPLC method for determination of temozolomide in human plasma.
E Gilant, M Kaza, A Szlagowska, K Serafin-Byczak, PJ Rudzki
Acta poloniae pharmaceutica 69 (6), 1347-1355, 2012
202012
Validated HPLC method for determination of cefuroxime in human plasma.
A Szlagowska, M Kaza, PJ Rudzki
Acta poloniae pharmaceutica 67 (6), 677, 2010
202010
Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?
M Kaza, M Karaźniewicz-Łada, K Kosicka, A Siemiątkowska, PJ Rudzki
Journal of Pharmaceutical and Biomedical Analysis 165, 381-385, 2019
172019
The toxicity of selected pharmaceuticals to the aquatic plant Lemna minor
M Kaza, G Nalecz-Jawecki, J Sawicki
Fresenius Environmental Bulletin 16 (5), 524-531, 2007
162007
Rapid and simplified HPLC-UV method with on-line wavelengths switching for determination of capecitabine in human plasma
E Piórkowska, M Kaza, J Fitatiuk, I Szlaska, T Pawiński, PJ Rudzki
Die Pharmazie-An International Journal of Pharmaceutical Sciences 69 (7 …, 2014
142014
Comprehensive graphical presentation of data from incurred sample reanalysis
PJ Rudzki, P Biecek, M Kaza
Bioanalysis 9 (12), 947-956, 2017
102017
Kompleksowa analiza ekotoksykologiczna wód powierzchniowych
J Sawicki, G Nałęcz-Jawecki, J Mankiewicz-Boczek, K Izydorczyk, ...
Projekt MNiL, P05F, 2007
102007
Incurred sample reanalysis: time to change the sample size calculation?
PJ Rudzki, P Biecek, M Kaza
The AAPS journal 21 (2), 28, 2019
62019
Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine
M Kaza, E Gilant, M Filist, I Szlaska, T Pawiński, PJ Rudzki
Clinical biochemistry 47 (13-14), 1313-1315, 2014
62014
Incurred sample reanalysis: adjusted procedure for sample size calculation
PJ Rudzki, K Buś-Kwaśnik, M Kaza
Bioanalysis 9 (21), 1719-1726, 2017
52017
Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol
M Filist, I Szlaska, M Kaza, T Pawinski
Biomedical Chromatography 30 (6), 953-961, 2015
52015
Bioequivalence study of 500 mg cefuroxime axetil film-coated tablets in healthy volunteers.
M Kaza, A Leś, K Serafin-Byczak, H Ksycińska, PJ Rudzki, P Gutkowskpi, ...
Acta poloniae pharmaceutica 69 (6), 1356-1363, 2012
52012
Evaluation of the toxicity of psychoactive compounds with the battery of bioassays
G Nałęcz-Jawecki, M Kaza, J Sawicki
Fresenius Environ Bull 17, 1257-1263, 2008
52008
HPLC-UV assay of imatinib in human plasma optimized for bioequivalence studies
M Kaza, M Piórkowska, Edyta, Filist, P Rudzki
Acta poloniae pharmaceutica 73 (6), 1495-1503, 2016
42016
Extended 3D and 4D cumulative plots for evaluation of unmatched incurred sample reanalysis
PJ Rudzki, M Kaza, P Biecek
Bioanalysis 10 (3), 153-162, 2018
32018
Bioequivalence study of 8 mg ondansetron film-coated tablets in healthy Caucasian volunteers
PJ Rudzki, M Kaza, A Leś, E Gilant, H Ksycińska, K Serafin-Byczak, ...
Drug research 64 (04), 220-224, 2014
22014
Walidacja metod bioanalitycznych stosowanych w badaniach farmakokinetycznych
M Kaza, A Szlagowska, P Rudzki
Farm Pol 65 (12), 839-844, 2009
12009
Visualizing bioanalytical methods–a near or distant future?
M Kaza, PJ Rudzki
Bioanalysis 12 (7), 427-429, 2020
2020
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20